Abstract |
Eotaxin plays a central role in the development of allergic disease, including atopic dermatitis, asthma, and nasal allergy. Interleukin (IL)-4 induces eotaxin production in normal human dermal fibroblasts. On the other hands, Transforming growth factor-beta ( TGF-beta), a multifunctional regulatory cytokine, affects many biological functions, including fibroblast growth and differentiation and Th2 cytokine regulation. In this study, we investigated the effect of TGF-beta on IL-4-induced eotaxin production by normal human fibroblasts, as well as the effect of suplatast tosilate, an antiallergic drug that selectively inhibits Th2 cytokine production. Dermal fibroblast treatment with IL-4 and TGF-beta for 24 h increased eotaxin production and expression of eotaxin mRNA, as measured by enzyme-linked immunosorbent assay (ELISA) and reverse-transcriptase polymerase chain reaction (RT-PCR), respectively. TGF-beta synergistically up-regulated eotaxin production and eotaxin mRNA expression when stimulated with IL-4. Suplatast tosilate dose-dependently inhibited eotaxin production induced by IL-4 or IL-4 plus TGF-beta. These results suggest that TGF-beta may regulate skin allergic inflammation by up-regulating eotaxin production in dermal fibroblasts. Suplatast tosilate might suppress this inflammation by inhibiting eotaxin production.
|
Authors | Sang Jae Bae, Jeong-Beom Lee, Kazuhiro Shimizu, Yutaka Kuwazuka |
Journal | Immunological investigations
(Immunol Invest)
Vol. 39
Issue 2
Pg. 93-102
(Jan 2010)
ISSN: 1532-4311 [Electronic] England |
PMID | 20136617
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Allergic Agents
- Arylsulfonates
- CCL11 protein, human
- Chemokine CCL11
- Chemotactic Factors, Eosinophil
- RNA, Messenger
- Sulfonium Compounds
- Transforming Growth Factor beta
- Interleukin-4
- suplatast tosilate
|
Topics |
- Anti-Allergic Agents
(pharmacology)
- Arylsulfonates
(pharmacology)
- Asthma
(drug therapy, immunology)
- Cells, Cultured
- Chemokine CCL11
(antagonists & inhibitors, biosynthesis)
- Chemotactic Factors, Eosinophil
(antagonists & inhibitors, biosynthesis)
- Dose-Response Relationship, Drug
- Drug Synergism
- Enzyme-Linked Immunosorbent Assay
- Fibroblasts
(drug effects, immunology, metabolism)
- Gene Expression Regulation
- Humans
- Interleukin-4
(pharmacology)
- Polymerase Chain Reaction
- RNA, Messenger
(antagonists & inhibitors, biosynthesis)
- Reverse Transcriptase Polymerase Chain Reaction
- Skin
(cytology)
- Sulfonium Compounds
(pharmacology)
- Transforming Growth Factor beta
(pharmacology)
- Up-Regulation
|